Class [5]
Pharmaceutical Products
Pharmaceutical preparations; Pharmaceutical preparations for activating cellular function; Pharmaceutical preparations for the prevention of diseases of the nervous system; Pharmaceutical preparations for treating sensory organ disorders; Pharmaceutical preparations for use in the prevention and treatment of neurodegenerative diseases; Pharmaceutical preparations for use in the prevention and treatment of neurodegenerative diseases, namely lysosomal storage disorders, Niemann-Pick disease, Alzheimer's disease, Parkinson's disease, prion disease, motor neurone disease, Huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; Drugs for medical purposes; Drugs for medical purposes, namely the prevention and treatment of neurodegenerative diseases; Drugs for medical purposes, namely the prevention and treatment of neurodegenerative diseases, namely lysosomal storage disorders, Niemann-Pick disease, Alzheimer's disease, Parkinson's disease, prion disease, motor neurone disease, Huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; Reagents for use in medical genetic testing; Diagnostic reagents for medical laboratory use; Diagnostic reagents for medical laboratory use, namely use in the detection and identification of neurodegenerative diseases; Diagnostic reagents for medical laboratory use, namely use in the detection and identification of neurodegenerative diseases, namely lysosomal storage disorders, Niemann-Pick disease, Alzheimer's disease, Parkinson's disease, prion disease, motor neurone disease, Huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; Amino acid preparations for medical purposes; Amino acid preparations for pharmaceutical use.
Class [42]
Computer & Software Services & Scientific Services
Scientific and technological services and research and design relating thereto; industrial analysis and research services; Scientific and technological services and research in the field of neurodegenerative diseases, namely lysosomal storage disorders, Niemann-Pick disease, Alzheimer's disease, Parkinson's disease, prion disease, motor neurone disease, Huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; industrial analysis and research services related to neurodegenerative diseases, namely lysosomal storage disorders, Niemann-Pick disease, Alzheimer's disease, Parkinson's disease, prion disease, motor neurone disease, Huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; design and development of computer hardware and software related to assays; Clinical trials; Conducting clinical trials for pharmaceutical products; Conducting clinical trials for neurodegenerative diseases, namely lysosomal storage disorders, Niemann-Pick disease, Alzheimer's disease, Parkinson's disease, prion disease, motor neurone disease, Huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; Medical laboratories for research related to neurodegenerative diseases, namely lysosomal storage disorders, Niemann-Pick disease, Alzheimer's disease, Parkinson's disease, prion disease, motor neurone disease, Huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; Providing information about the results of clinical trials for pharmaceutical products; Clinical research; Medical laboratories; Research relating to molecular sciences; Medical research; Genetic research; Research in the field of gene therapy; Biopharmaceutical research for development of targeted therapies for use in the treatment of carcinomas and neurodegenerative diseases; scientific, biochemical, research and development services in the field of neurodegenerative diseases; Providing scientific information in the field of medical disorders and their treatment; Pharmaceutical drug development services.
